학술논문
Longitudinal Assessment of Minimal Residual Disease (MRD) in the ATLAS Randomized Phase 3 Trial of Post-Transplant Treatment with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Versus Lenalidomide (R) Alone in Patients with Newly Diagnosed Multiple Myeloma (NDMM)
Document Type
Journal
Author
Kubicki, Tadeusz; Dytfeld, Dominik; Wrobel, Tomasz; Jamroziak, Krzysztof; Robak, Pawel; Czyz, Jaroslaw; Tyczynska, Agata; Druzd-Sitek, Agnieszka; Giannopoulos, Krzysztof; Nowicki, Adam; Szczepaniak, Tomasz; Lojko-Dankowska, Anna; Matuszak, Magdalena; Gil, Lidia; Pula, Bartosz Michal; Rybka, Justyna; Majcherek, Maciej; Usnarska-Zubkiewicz, Lidia; Szukalski, Lukasz; Konska, Agnieszka; Zaucha, Jan M.; Walewski, Jan; Mikulski, Damian; Czabak, Olga; Robak, Tadeusz; Kruk-Kwapisz, Dorota; Lahoud, Oscar Boutros; Zonder, Jeffrey A.; Griffith, Kent; Stefka, Andrew T.; Jiang, Ken; Cooperrider, Jennifer H.; Derman, Ben A.; Jakubowiak, Andrzej J.
Source
Subject
Language
English
ISSN
15280020